Effects of gonadal steroids in women with a history of postpartum depression.

By M. Bloch, Peter Schmidt, M. Danaceau, Jean H. Murphy, L. Nieman, D. Rubinow. American Journal of Psychiatry, 2000

919 citations recorded by the source corpus.

Subfields: Pharmacology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/88fd7b0c5130d7481d8add18b6273d1f4ea68c6d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pharmacology

1. G. Sanacora
2. R. Duman
3. Christine Kuehner
4. K. Al-Harbi
5. Amanda J. Rose
6. K. Rudolph

In Public Health, Environmental and Occupational Health

1. M. O’Hara
2. Christine Kuehner
3. Jennifer E. McCabe
4. C. N. Epperson
5. N. Sarvaiya
6. M. Altemus

Citations in the corpus

• Sex differences in anxiety and depression clinical perspectives (2014, background): “…no history of postnatal depression and a comparison group with a history of postpartum depression suggests that with exposure to and withdrawal of pregnancy levels of estradiol and progesterone, there are subset of women who are particularly vulnerable to develop depression (Bloch et al., 2000).”
• Postpartum depression: current status and future directions. (2013, background): “The authors concluded that these findings point to the importance of estradiol and progesterone in the etiology of PPD and perhaps identify a subgroup of women who are particularly sensitive to the mood-destabilizing effects of perinatal changes in gonadal steroid levels (Bloch et al. 2000).”
• Gender differences in unipolar depression: an update of epidemiological findings and possible explanations (2003, background): “One study (77) showed that the simulation of the hormonal milieu after delivery caused affective symptoms in some women who previously had suffered from PPD.”
• Biological and Psychosocial Predictors of Postpartum Depression: Systematic Review and Call for Integration (2015, background): “Thus, shifts in estrogen and progesterone during pregnancy and post partum may contribute to PPD (Bloch et al. 2000).”
• Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments (2019, background): “Allopregnanolone was initially targeted for its potential in postpartum depression, to replace the precipitous drop that occurs at birth, resulting in reduced GABAAR transmission (Bloch et al., 2000; Schiller et al., 2015).”